Cheng-Jeng Tai |
------>authors3_c= ------>paper_class1=1 ------>Impact_Factor=2.739 ------>paper_class3=2 ------>paper_class2=4 ------>vol=48 ------>confirm_bywho=None ------>insert_bywho=cjtai ------>Jurnal_Rank=49.6 ------>authors4_c= ------>comm_author=1 ------>patent_EDate=None ------>authors5_c= ------>publish_day=1 ------>paper_class2Letter=None ------>page2=932 ------>medlineContent= ------>unit=E0109 ------>insert_date=20091012 ------>iam=1 ------>update_date=None ------>author=??? ------>change_event=1 ------>ISSN= ------>authors_c= ------>score=-10000 ------>journal_name=Acta Oncologica ------>paper_name=Salvage therapy with sorafenib plus vinblastine and fluorouracil for metastatic renal cell carcinoma ------>confirm_date=None ------>tch_id=092092 ------>pmid=no found ------>page1=931 ------>fullAbstract=no found ------>tmu_sno=None ------>sno=22490 ------>authors2= ------>authors3= ------>authors4= ------>authors5= ------>authors6= ------>authors6_c= ------>authors=Cheng-Jeng Tai ------>delete_flag=0 ------>SCI_JNo=None ------>authors2_c= ------>publish_area=0 ------>updateTitle=no found ------>language=2 ------>check_flag=None ------>submit_date=None ------>country=None ------>no=6 ------>patent_SDate=None ------>update_bywho=None ------>publish_year=2009 ------>submit_flag=None ------>publish_month=8 |